Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells
Authors:
- 11 December 2012
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 53 (9) , 2012-2019
Abstract
Background: Our ex vivo expansion procedure starting from cord blood (CB) CD34+ cells enabled expansion of committed progenitors (CPs) without a negative impact on hematopoietic stem cells (HSCs) exhibiting both short‐ and long‐term repopulating capacity. Upgraded to clinical scale (Macopharma HP01 in the presence of stem cell factor, FLT3‐L [100 ng/mL each], granulocyte–colony‐stimulating factor [10 ng/mL], and thrombopoietin [20 ng/mL]), it is being used for an ongoing clinical trial (adult allogeneic context) yielding promising preliminary results. Transplantation of ex vivo expanded CB cells is becoming a reality, while the issue of expanded cells' cryopreservation emerges as an option that allows the conservation of the product for transportation and future use. Here, we investigated whether it is possible to maintain the functional HSC and CP properties after freezing and thawing of expanded cells.Study Design and Methods: We compared cryopreservation efficiency of the ex vivo expanded CB cells using the standard protocol (freezing solution human serum albumin (HSA)‐dimethyl sulfoxide [DMSO]) with the newly designed protocol based on an enriched freezing solution (HP01‐DMSO) with respect to the viability index, number of CD34+ and total cells, and recovery of CPs (colony‐forming units) and HSCs (NOG/Scid/gamma–null mice engraftment).Results: Cryopreservation and thawing of expanded CB cells using the “standard” procedure (HSA‐DMSO) reduced recovery of the CPs (40%) and HSCs (drastically decreasing engraftment capacity). HP01‐based protocol resulted in improvement of preservation of both CPs (>60%) and HSCs (nonaltered engraftment capacities).Conclusion: Functional maintenance of the expanded graft by cryopreservation is feasible in conditions compatible with human cell therapy requirements.Keywords
This publication has 23 references indexed in Scilit:
- Functional Stability (at +4°C) of Hematopoietic Stem and Progenitor Cells Amplified Ex Vivo from Cord Blood CD34+ CellsCell Transplantation, 2013
- Rapid and Sustained Engraftment of a Single Allogeneic Ex-Vivo Expanded Cord Blood Unit (CBU) After Reduced Intensity Conditioning (RIC) in Adults. Preliminary Results of a Prospective TrialBlood, 2011
- Clinical-Scale Cultures of Cord Blood CD34+ Cells to Amplify Committed Progenitors and Maintain Stem Cell ActivityCell Transplantation, 2011
- Very Low O2 Concentration (0.1%) Favors G0 Return of Dividing CD34+ CellsStem Cells, 2006
- A clinical‐scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by use of a new serum‐free mediumTransfusion, 2005
- Cord Blood Processing by Using a Standard Manual Technique and Automated Closed System "Sepax" (Kit CS-530)Stem Cells and Development, 2005
- Simultaneous Maintenance of Human Cord Blood SCID‐Repopulating Cells and Expansion of Committed Progenitors at Low O 2 Concentration (3%)Stem Cells, 2004
- An Efficient Large-Scale Thawing Procedure for Cord Blood Cells Destined for Selection and Ex Vivo Expansion of CD34 + CellsJournal of Hematotherapy & Stem Cell Research, 2003
- Comparison of CD34+ cell collection on the CS-3000+ and Amicus blood cell separatorsTransfusion, 2003
- A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin VJournal of Immunological Methods, 1995